Nearly everyone has suffered in some way from COVID-19 and Mammoth is no different. However life has gone on, and in addition to bringing to Canada a sorely needed innovative economic development program, we have pivoted our basic business to draw on our broader core strengths. 

While continuing to assist early stage health innovation companies with business development (and due diligence guidance for those raising funds), Mammoth has expanded its scope to now offer direct sales and agency support to technologies targeted to the identification, treatment and eradication of COVID-19. 

With this in mind, Mammoth is adding the caption “Canada’s pathogen-fighting technology source” to its wordmark.

Our first engagement, under this new division, is UV Angel. We have also assisted clients in their Health Canada clearance for various products including home-based rapid antigen tests. As well, we are providing Business Development support to Botanisol Analytics who are conducting a field test of their Autonomous Disease Detecting Kiosk™ for the Ministry of Health and Social Services of Namibia. If you have a product you feel fits and is dedicated towards returning the world to “normal,” OR protecting against the next pandemic, please contact us. In the meantime, stand by as we continue to grow. 

EXPERIENCE
As the creator of the Health Ecosphere and having launched the CreateIT Now incubator, which together produced dozens of Healthtech companies, Dan Wasserman (Mammoth’s founder) has also led Direct sales, Concept sales, and Strategic partnerships. 

Contact: Dan Wasserman directly at dan@danwasserman.com or 1-416-835-3500.